Inspire Napa Valley (INV), benefiting the Alzheimer's Association, is committed to inspiring change in the Napa Valley by bringing wine enthusiasts and industry leaders together to advance research to end Alzheimer’s and dementia while enhancing care for those living with the disease. INV will raise critical funds to help families in Northern California struggling with Alzheimer’s care and fund cutting-edge research nationwide. 


When wine industry leader, Kerrin Laz’s mother was diagnosed with early onset Alzheimer’s in 2014, she knew that she had to do something to help fight this disease. In 2017, Kerrin founded Inspire Napa Valley to raise critical funds and awareness of Alzheimer’s disease in the Napa Valley.  The inaugural INV wine weekend will be curated by Kerrin, one of Napa Valley’s most beloved wine personalities. 


Join us for the inaugural Inspire Napa Valley Wine Weekend, May 4 & 5, 2018 featuring:

  • VIP dinner at an exclusive, private venue
  • VIP wine seminar featuring a 1,000 point wine tasting experience with notable guest judges
  • Walk-around wine tasting featuring 30-40 of the most sought-after, cult wineries of Napa Valley
  • Seated dinner, live auction, & paddle raise hosted in the barrel room at the Culinary Institute of America Greystone


Proceeds from Inspire Napa Valley will support the Alzheimer’s Association. Our goal is to raise more than $1 million to address this rapidly growing health crisis.

  • Alzheimer’s disease is the nation’s sixth-leading cause of death and one of the costliest chronic diseases to our society.
  • It is the only disease among the top 10 causes of death in America that cannot be prevented, cured or even slowed.
  • More than 5 million Americans are living with Alzheimer’s disease – 200,000 of which are age 65 or younger.
  • In 2016, more than 15 million family members and friends provided 18.2 billion hours of unpaid care to people with Alzheimer’s and other dementias, at an economic value of over $230 billion. Unless something is done, in 2050, Alzheimer's is projected to cost more than $1 trillion.